‘Dead wrong’: Lawmakers, advocates decry rejection of MDMA-assisted therapy by FDA panel

A Food and Drug Administration panel’s surprising recommendation this week to reject the use of MDMA, commonly known as ecstasy, to treat PTSD was a blow to advocates and lawmakers who champion the treatment as a game changer for mental health in the United States. The FDA, which designated MDMA-assisted therapy as a “breakthrough therapy”...

0

No comments

Read more